# FDA recall D-0703-2017

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2017-03-28.

## Product

PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v)  240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87

## Reason for recall

Failed Stability Specifications

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0703-2017
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-03-28
- **Report date:** 2017-05-17
- **Termination date:** 2017-10-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0703-2017

## Citation

> AI Analytics. FDA recall D-0703-2017. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0703-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*